 Home > Medical News > Medicines Company News > Russia Direct Investment Fund and Hualan Biotechnology reached an agreement

Russia Direct Investment Fund and Hualan Biotechnology reached an agreement

 Last Update: 2021-07-08
 Source: Internet
 Author: User

Tags

1 3 pentadiene

direct incorporation

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The Russian Direct Investment Fund (RDIF, Sovereign Wealth Fund of the Russian Federation) and Hualan Biovaccine Co.
, Ltd.
(a subsidiary of Hualan Bioengineering Co.
, Ltd.
, a leading biopharmaceutical company in China, and the largest influenza vaccine manufacturer in China) announced an agreement.
The world's first registered vaccine against coronavirus, "Sputnik V", will be produced in China with more than 100 million doses per year
.

The production volume enables more than 50 million people to be vaccinated
.

RDIF and Hualan Biovaccine Co.

The "Sputnik V" vaccine has been registered in 60 countries with a total population of 3 billion
.

The effectiveness of "Sputnik V" is 91.

The vaccine is based on a mature and well-researched human adenovirus vector platform.
Two different vectors are used for two vaccination during the vaccination process, which has a longer-lasting immunity than a vaccine that uses the same administration mechanism for two vaccination
.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) said:

"The cooperation agreement with China's leading vaccine manufacturer Hualan Biovaccine Co.
, Ltd.
will enable us to meaningfully expand the production capacity of "Sputnik V"
.

China is Russia’s main partner in vaccine production, and Russian vaccines are already available in various regions of the world.

The Russian Direct Investment Fund (RDIF) was established in 2011, mainly to make equity investments in Russian companies together with leading foreign financial and strategic investors
.

The fund is a catalyst for direct investment in the Russian economy

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.